MPH / Department of Public Health / Background: South Africa presently has a very high HIV burden. It has adopted the UNAIDS
“90-90-90 targets” to curb its HIV burden. This target aims to attain sustained viral suppression in
90% of all persons receiving antiretroviral therapy. This is supported by several studies. Studies
to observe if patients are achieving and sustaining viral suppression in Limpopo, South Africa, are
few.
Objective: To investigate the viral and immunologic responses of patients in Vhembe District to
highly active antiretroviral therapy (HAART) between the 1st of January 2004 and 31st of July
2016.
Methodology: This was a retrospective medical record review conducted in Vhembe District in
rural Limpopo. It included the medical records of 1247 individuals from Thohoyandou Community
Health Centre. Analysis was done using SPSS 24.0. To model the factors associated with virologic
and immunologic responses, each independent variable was tested for association with the
dependent variable (viral suppression and CD4 count increase of ≥ 50 cells/μL from baseline to 6
months). The independent variables included age, year of initiation, gender, marital status, baseline
BMI, haemoglobin, clinical stage and estimated creatinine clearance. The Pearson Chi square (X2)
was used for all categorical independent variables and the t-test, for all continuous independent
variables, to test for association. The estimate used was a 95% confidence interval, and a p-value
of < 0.05 was considered significant.
Results: The study showed that 52.6% of individuals were in clinical stage I at baseline. Viral
suppression (viral load < 50 copies/ml) at 6 months was 64% (n = 648), 72% (n =193) at 60 months
and 94% (n = 16) at 132 months. Fifty-nine percent had consistent viral suppression for a period
of at least 6 months. Consistent viral suppression (viral load < 50 copies/ml on at least one
consecutive occasion without any intervening viral load > 50 copies/ml) for at least 54 months was
only 14%, while 2.3% had a delay in switching from a failing regimen. The mean CD4 count at
baseline was 227 cells/μL, and 538 cells/μL at 60 months. The mean CD4 cell count increase from
baseline to 6 months was 190 cells/μL. The immuno-virologic discordance was 27%. Patients with
higher baseline CD4 count and females were significantly (p = 0.001 and 0.031 respectively) more
likely to achieve viral suppression at 6 months. Those below 45 years and females were
v
significantly (p = 0.011 and 0.043 respectively) more likely to achieve adequate CD4 count
increase at 6 months.
Conclusions: The proportion of individuals with viral suppression in the District increased from
6 months onwards, and is fairly adequate. However, sustainability of viral suppression, once
attained, is low. Adequate immunologic response, however, seems high. Males and age group
above 45 years appear to have poorer responses to HAART.
| Identifer | oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:univen/oai:univendspace.univen.ac.za:11602/703 |
| Date | 18 May 2017 |
| Creators | Aniekan, Adet |
| Contributors | Bessong, P. O., Akinsola, H. A. |
| Source Sets | South African National ETD Portal |
| Language | English |
| Detected Language | English |
| Type | Dissertation |
| Format | 1 online resource (61 leaves : color Illustrations) |
| Rights | University of Venda |
Page generated in 0.0016 seconds